Eyeworld

August 2011 T he 2012 ASCRS Winter Update may be a few months away, but it's never too early to reserve your spot for this 4-day educa- tional program. Now in its fifth year, the next Winter Update will be held at the Fairmont Mayakoba, in Playa del Carmen, Mexico, from February 16-20, 2012. Attendees will receive a much-needed respite from the cold winter weather covering most of the U.S. Program chairs are Roger F. Steinert, M.D., Irving H. Leopold Professor and chair of ophthalmol- ogy, School of Medicine, University of California, Irvine; Stephen S. Lane, M.D., adjunct clinical profes- sor, University of Minnesota, Min- neapolis; and Edward Holland, M.D., professor of ophthalmology, University of Cincinnati, and direc- tor, cornea service, Cincinnati Eye Institute. Roanoke, Texas. Of course, Mexico isn't all work and no play. The Fairmont Mayakoba is a luxury hotel on a gated 45-acre resort, located about 40 miles from Cancun. It boasts a private beach, five swimming pools, a variety of dining options including two four-star restaurants, and an 18- hole golf course. Playa del Carmen has a subtropical climate, with tem- perature averages ranging between 68 and 84 degrees in February. The water is warm enough for swimming and there's very little rain that time of year. Guests and children are wel- come at the Winter Update meeting. Guest and family registration fees in- clude most meals throughout your time in Mexico. Get the best price and register early. The lowest registration prices are available through Sept. 9 and increase incrementally as the date nears. For more information, contact Laura Johnson at ljohnson@ ascrs.org, or visit www. winterupdate. org. EW by Faith A. Hayden EyeWorld Staff Writer Winter Update 2012: Playa del Carmen, Mexico "The ASCRS Winter Update is returning to the wonderful Fairmont Mayakoba in Playa del Carmen, Mexico. This location has always re- ceived great reviews from our past Winter Update meeting attendees as a wonderful hotel with a great beach and excellent weather," Dr. Holland said. "The meeting format will con- tinue to be the case-based sessions with faculty/audience interaction," he continued. "The meeting has grown in attendance every year, but the program chairs are committed to keeping the meeting informal with as much audience participation as possible." The clinical program begins on Friday, Feb. 17, with case presenta- tions on complicated cataract cases and cornea. Other topics to be cov- ered during the meeting include new technology in cataract and lens- related surgery, retina, a video com- plications seminar, challenging cases for comprehensive clinicians, glau- coma, and optional CME luncheon workshops. Like last year, the ASOA Practice Management Track will also be rep- resented. That program lasts 3 days and begins on Feb. 17. Faculty in- cludes but is not limited to Nancey K. McCann, director, government relations, ASCRS•ASOA; E. Ann Rose, president of Rose & Associates, Duncanville, Texas; Lisa M. Gangi, C.O.E., ASOA president, Sarasota, Fla.; and Paul Stubenbordt, Stubenbordt Consulting Inc., © 2011 Novartis AG 5/11 TOR11350PI CAUTION: Restricted by law to sale by or on the order of a physician. DESCRIPTION: The AcrySof ® IQ Toric Intraocular Lenses (IOLs) are artificial lenses implanted in the eye of adult patients following cataract surgery. These lenses are designed to correct pre-existing corneal astigmatism and provide distance vision. WARNINGS: You may experience and need to contact your eye doctor im- mediately if you have any of the fol- lowing symptoms while using the an- tibiotic eye drops prescribed by your doctor: itching, redness, watering of your eye, sensitivity to light. PRECAUTIONS: The safety and effec- tiveness of the AcrySof ® IQ Toric IOL has not been established in patients with eye conditions, such as an in- crease in eye pressure (glaucoma) or complications of diabetes in the eye (diabetic retinopathy). As with any surgical procedure, there are risks in- volved. These risks may include but are not limited to infection, damage to the lining of the cornea, the layer which lines the inside back wall of your eye may become separated from the tissue next to it (retinal detach- ment), inflammation or swelling inside or outside the eye, damage to the iris (the colored diaphragm around the pupil), an increase in eye pressure and secondary surgical procedure. Your eye doctor will discuss all risks and benefits to you before your surgery. In some cases, patients left with uncor- rected corneal astigmatism following cataract surgery may not benefit from the aspheric surface (the part the IOL that is designed to improve vision sharpness in low light) without addi- tional use of spectacles. If you have high corneal astigmatism (i.e. greater than or equal to 2.5 D) and a cataract you may be experiencing visual symp- toms. These visual symptoms may or may not fully improve after implanta- tion with an AcrySof ® IQ Toric High Cylinder Power IOLs after cataract surgery. A toric IOL corrects astig- matism only when it is placed in the correct position in the eye. There is a possibility that the toric IOL could be placed incorrectly or could move within the eye. This may result in less improvement or a reduction in vision because your astigmatism has not been fully corrected, or it may cause visual symptoms. www.AcrySofIQTORIC.com 1 7/12/11 12:38 PM

• Cover